Noticias del mercado de valores
Últimas noticias financieras · Actualizado May 23, 2026
Le pregunté a ChatGPT que me explicara Ethereum como si tuviera 12 años
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
¿Keir Starmalade, alguien? ¿De verdad tendrá que ser rehecha la marca de la mermelada en el Reino Unido?
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
‘No es exactamente Greggs’: los creadores de TikTok ponen a prueba las panaderías ‘gentrificadas’ de Londres
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
Goldman Sachs eleva su objetivo de precio para PVH Corp. (PVH) a $93 desde $83
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) Informa Datos Positivos de la Semana 52 del Ensayo Fase 2 New InsiGHTS
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research Inicia Cobertura de BeOne Medicines AG (ONC) con Calificación Outperform
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
Mizuho reduce su precio objetivo de Autolus Therapeutics plc (AUTL) a $10 desde $12
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) Firma Acuerdo con Gilead sobre los Activos de Ouro Medicines
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital Recorta su Precio Objetivo para Bicycle Therapeutics plc (BCYC) a $7 desde $11
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
Los Mejores ETFs Para $100 Petróleo Para Comprar Ahora Mismo
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen Eleva su Objetivo de Precio para Marex Group plc (MRX) a $66
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …
El ETF de Oro con 83.8 Mil Millones de Dólares en Activos y un 0.25% de Tasa que los Inversores Eligen Sobre GLD
The Gold ETF With $83.8 Billion in Assets and a 0.25% Fee Investors Keep Choosing Over GLD
The panel is divided on IAU's suitability for current portfolios. While some argue it's a useful diversifier and hedge, others …